Physician profile
Jean E Wardlow
NPI 1316984313
$4,423.32
in general payments reported to CMS, 2019-2025
35 companies · $1,002 in 2025
The $1,002 reported for 2025 was more than what 85% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $206 · 2021: $455 · 2022: $557 · 2023: $841 · 2024: $789 · 2025: $1,002.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,599 · Education: $32.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,599.21 |
| Education | $32.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $697.77 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals Lp | $498.97 | 2019-2025 | Airsupra, Farxiga |
| Pfizer INC. | $398.19 | 2019-2025 | |
| Abbvie INC. | $376.53 | 2019-2025 | Ubrelvy, Qulipta, Vraylar |
| Bayer Healthcare Pharmaceuticals INC. | $295.05 | 2021-2025 | |
| Lilly USA, LLC | $280.75 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $208.01 | 2019-2025 | Trelegy Ellipta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $206.03 | 2019-2025 | Jardiance |
| Amgen INC. | $203.59 | 2019-2025 | Evenity, Prolia |
| Astellas Pharma US INC | $166.29 | 2019-2024 | Veozah, Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $88.56 | 2023-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $84.84 | 2022-2024 | Camzyos, Eliquis |
| Exact Sciences Corporation | $84.71 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sanofi-Aventis U.S. LLC | $77.06 | 2021-2022 | |
| Eisai INC. | $68.21 | 2020-2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $67.95 | 2019-2022 | |
| Dexcom, INC. | $64.81 | 2019-2023 | Dexcom G6 Transmitter |
| Allergan, INC. | $61.25 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $52.29 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.28 | 2022-2023 | Xifaxan, Trulance |
| Boston Scientific Corporation | $44.21 | 2024-2025 | Watchman Access System |
| Verona Pharma, INC. | $43.13 | 2025 | Ohtuvayre |
| Idorsia Pharmaceuticals US INC | $35.58 | 2022-2025 | Quviviq |
| Regeneron Healthcare Solutions, INC. | $32.14 | 2019 | |
| Stryker Corporation | $31.41 | 2022-2025 | Omnicurve |
| Abbott Laboratories | $31.34 | 2022-2023 | Freestyle Libre 3 |
| Teva Pharmaceuticals USA, INC. | $28.30 | 2019 | |
| Harmony Biosciences LLC | $24.65 | 2023 | Wakix |
| Axsome Therapeutics, INC. | $23.02 | 2025 | Auvelity |
| Almatica Pharma LLC | $22.89 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $18.81 | 2025 | Opsumit, Uptravi |
| Currax Pharmaceuticals LLC | $17.85 | 2025 | Contrave |
| Daiichi Sankyo INC. | $15.26 | 2023 | Injectafer |
| Supernus Pharmaceuticals, INC. | $15.00 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $14.59 | 2023 | Purewick Female External Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jean Wardlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.